Drug recall

Apheresis Fresh Frozen Plasma

FDA recall event 98450 · Class II · American National Red Cross, Penn Jersey Region

Key facts

Event ID 98450
Recall numbers B-0031-2026, B-0032-2026, B-0033-2026, B-0034-2026, B-0035-2026, B-0036-2026, B-0037-2026, B-0038-2026, B-0039-2026
Recalling firm American National Red Cross, Penn Jersey Region
Product type Biologics
Products Apheresis Fresh Frozen Plasma, Apheresis Red Blood Cells, Leukocytes Reduced, Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, Cryoprecipitated AHF, PF24 Plasma and 4 more
Classification Class II
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Apheresis Fresh Frozen Plasma, collected in a manner that compromises the sterility of the collection system, were distributed., Apheresis Red Blood Cells, Leukocytes Reduced, collected in a manner that compromises the sterility of the collection system, were distributed., Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, collected in a manner that compromises the sterility of the…
Initiation date Apr 3, 2024
Report date Apr 1, 2026
Termination date Mar 23, 2026
City Philadelphia
State PA
Country United States
FEI number 2573021

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls